Photocure ASA (OSL:PHO)

Norway flag Norway · Delayed Price · Currency is NOK
54.10
+0.50 (0.93%)
Jun 27, 2025, 4:25 PM CET
-9.83%
Market Cap 1.44B
Revenue (ttm) 532.69M
Net Income (ttm) 2.14M
Shares Out 26.61M
EPS (ttm) 0.08
PE Ratio 673.26
Forward PE 151.52
Dividend n/a
Ex-Dividend Date n/a
Volume 66,379
Average Volume 40,713
Open 54.00
Previous Close 53.60
Day's Range 54.00 - 54.70
52-Week Range 47.00 - 65.60
Beta 0.61
RSI 65.06
Earnings Date Jul 30, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen... [Read more]

Sector Healthcare
Founded 1993
Employees 101
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.